Literature DB >> 11818466

Attention deficit/hyperactivity disorder across the lifespan.

Timothy E Wilens1, Joseph Biederman, Thomas J Spencer.   

Abstract

Attention deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder presenting for treatment in youth. ADHD is often chronic with prominent symptoms and impairment spanning into adulthood. ADHD is often associated with co-occurring anxiety, mood, and disruptive disorders, as well as substance abuse. The diagnosis of ADHD by careful review of symptoms and impairment is both reliable and valid. Recent genetic, imaging, neurochemistry, and neuropsychological data support the biological underpinning of the disorder. All aspects of an individual's life must be considered in the diagnosis and treatment of ADHD. Pharmacotherapy, including stimulants, antidepressants, and antihypertensives, plays a fundamental role in the management of ADHD across the lifespan.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818466     DOI: 10.1146/annurev.med.53.082901.103945

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  98 in total

1.  The intraindividual impact of ADHD on the transition of adulthood to old age.

Authors:  Florence Philipp-Wiegmann; Petra Retz-Junginger; Wolfgang Retz; Michael Rösler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-10-05       Impact factor: 5.270

2.  Child attention deficit hyperactive disorder co morbidities on family stress: effect of medication.

Authors:  Desiree Silva; Stephen Houghton; Erika Hagemann; Peter Jacoby; Brad Jongeling; Carol Bower
Journal:  Community Ment Health J       Date:  2014-08-26

3.  Neuropsychological and dimensional behavioral trait profiles in Costa Rican ADHD sib pairs: Potential intermediate phenotypes for genetic studies.

Authors:  Viviana A Peskin; Anna Ordóñez; R Scott Mackin; Kevin Delucchi; Silvia Monge; James J McGough; Denise A Chavira; Monica Berrocal; Erika Cheung; Eduardo Fournier; Judith A Badner; Luis Diego Herrera; Carol A Mathews
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-03-31       Impact factor: 3.568

4.  Evolution of Symptoms and Syndromes of Psychopathology in Young People with Mental Retardation.

Authors:  Stewart L Einfeld; Bruce J Tonge; Kylie Gray; John Taffe
Journal:  Int Rev Res Ment Retard       Date:  2006

5.  Treatment Effects of Parent-Child Focused Evidence-Based Programs on Problem Severity and Functioning among Children and Adolescents with Disruptive Behavior.

Authors:  Sarah Vidal; Christian M Connell
Journal:  J Clin Child Adolesc Psychol       Date:  2018-06-08

Review 6.  Attention-deficit/hyperactivity disorder and its comorbidities in women and girls: an evolving picture.

Authors:  Patricia O Quinn
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

Review 7.  Psychosocial treatments for attention-deficit/hyperactivity disorder.

Authors:  Laura A Knight; Mary Rooney; Andrea Chronis-Tuscano
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

8.  The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Lenard Adler; Russell Barkley; Joseph Biederman; C Keith Conners; Olga Demler; Stephen V Faraone; Laurence L Greenhill; Mary J Howes; Kristina Secnik; Thomas Spencer; T Bedirhan Ustun; Ellen E Walters; Alan M Zaslavsky
Journal:  Am J Psychiatry       Date:  2006-04       Impact factor: 18.112

9.  Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11.

Authors:  Matthew N Ogdie; Simon E Fisher; May Yang; Janeen Ishii; Clyde Francks; Sandra K Loo; Rita M Cantor; James T McCracken; James J McGough; Susan L Smalley; Stanley F Nelson
Journal:  Am J Hum Genet       Date:  2004-08-03       Impact factor: 11.025

10.  Preferences for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): a discrete choice experiment.

Authors:  Axel C Mühlbacher; Ina Rudolph; Hans-Joachim Lincke; Matthias Nübling
Journal:  BMC Health Serv Res       Date:  2009-08-13       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.